Search

A recent study conducted by Arizona State University focused on the benefits of dietary choline supplementation in adult Ts65Dn mouse models of Down Syndrome. The research aimed to assess the effects of choline supplementation on cognition and co-morbidities associated with Down Syndrome. While the study found that choline supplementation did not improve spatial learning deficits, it did enhance cognitive flexibility, reduce weight gain and inflammation, and improve glucose metabolism in the mice. The findings suggest that choline supplementation in adulthood may have positive effects on behavioral and biological factors related to general well-being in individuals with Down Syndrome. [Extracted from the article]

Researchers from National University in Tehran, Iran, conducted a study on male Wistar rats to investigate the impact of high-intensity interval training (HIIT) and L-carnitine on liver metabolism. The study found that the combination of HIIT and L-carnitine increased the expression of MCT1, PGC-1a, and CS in the liver, potentially preventing liver diseases related to fat accumulation. The research suggests that HIIT exercises and L-carnitine supplements may have beneficial effects on liver health. [Extracted from the article]

A study conducted at Kerman University of Medical Sciences in Iran explored the impact of L-Carnitine supplementation and exercise training on apoptosis in male rats. The research found that L-Carnitine supplementation, particularly in combination with high-intensity interval training (HIIT), significantly reduced apoptosis by increasing anti-apoptotic factors and decreasing proapoptotic proteins. The study suggests that L-Carnitine may be a promising supplement to mitigate exercise-induced cell damage and improve cell viability. This research may have implications for human studies evaluating the benefits of L-Carnitine supplementation with exercise training. [Extracted from the article]

Researchers at the Indian Institute of Petroleum in Visakhapatnam, India, have conducted a study on the synthesis and characterization of choline chloride: urea deep eutectic solvent (DES) and its impact on surfactant behavior. The incorporation of DES into surfactant solutions enhanced surfactant adsorption at interfaces and modified the wettability of sandstone. The study suggests that DES has potential applications in nanoscience, drug delivery systems, colloids, catalysis, and other fields. This peer-reviewed research provides insights into the physicochemical properties of DES and its synergistic effects in binary surfactant systems. [Extracted from the article]

A recent study conducted at the University of Florida explored the potential benefits of carnitine supplementation in individuals with Progressive Supranuclear Palsy (PSP), a neurodegenerative disorder. The research highlighted the role of mitochondrial dysfunction in PSP and observed improvements in symptoms such as tremors and fatigue following levocarnitine supplementation in a 65-year-old patient. While further investigation is needed to fully understand the impact of carnitine and other nutritional supplements on PSP, this study provides valuable insights into potential treatment avenues for this condition. [Extracted from the article]

Researchers at Ain Shams University conducted a study on the metabolic profile of full-term infants born to diabetic mothers. The study found that maternal diabetes during pregnancy can lead to alterations in amino acid concentrations and the carnitine shuttle pathway of the offspring. The research compared levels of amino acids and acylcarnitines in cord blood samples of infants of diabetic mothers to healthy newborns, highlighting differences in metabolomic profiles. This study sheds light on the potential risks and consequences of maternal diabetes on the metabolic health of newborns. [Extracted from the article]

The article discusses the impact of hepatic inactivation of Carnitine Palmitoyltransferase 1a (CPT1a) on apolipoprotein B containing lipoproteins in mice. Studies show that genetic variants and methylation status of CPT1a are associated with reductions in circulating apolipoprotein B-containing lipoproteins in humans. The research suggests that liver-specific deletion of Cpt1a leads to lower levels of apolipoprotein B, LDL-cholesterol, and LDL particle number in mice, indicating accelerated clearance of these lipoproteins. The findings provide mechanistic insight into the role of CPT1a in regulating lipid metabolism and circulating lipoproteins. [Extracted from the article]

A recent study conducted at Princess Nourah bint Abdulrahman University in Riyadh, Saudi Arabia, explored the cardioprotective effects of grape seed extract and L-Carnitine against Doxorubicin-induced cardiac toxicity in male rats. The research found that both grape seed extract and L-Carnitine significantly mitigated ECG abnormalities, reduced lipid peroxidation, improved antioxidant enzymes, and decreased inflammation markers. These findings suggest that grape seed extract and L-Carnitine may offer substantial cardioprotective benefits against Doxorubicin-induced cardiotoxicity through their antioxidant and anti-inflammatory properties. [Extracted from the article]

A study conducted at Ahvaz Jundishapur University of Medical Sciences in Iran explored the protective effects of betaine against testicular damage induced by methotrexate in mice. The research found that betaine restored testosterone levels, reduced oxidative stress, improved sperm quality, and decreased apoptosis in testicular tissue affected by methotrexate. The study concluded that betaine mitigates testicular harm by inhibiting apoptosis and reducing oxidative stress levels. This research has been peer-reviewed and provides valuable insights into potential treatments for methotrexate-induced testicular damage. [Extracted from the article]

A patent application has been submitted for a composition and methods of treatment using synergistically-enhanced supplementation by inventor Alexy Goldstein. The application focuses on transdermal supplementation for improving metabolic performance, utilizing medium-chain triglycerides, amino acids, cannabinoids, and zeatin. The inventor aims to address skin protection and repair by targeting oxidative stress and glycation processes, tailoring products to different skin types for optimal results. The patent application emphasizes the need for a comprehensive approach to skin health through transdermal delivery of active ingredients. [Extracted from the article]

Researchers from Capital Medical University in Beijing, China, conducted a study on atherosclerosis, a leading cause of mortality globally. They found that Acetyl-L-carnitine (ALC) supplementation reduced plasma cholesterol levels and inhibited atherosclerosis in mice by modulating cholesterol metabolism through SREBP2-dependent cholesterol biosynthesis. The study suggests that ALC could be a potential therapeutic target for atherosclerotic cardiovascular disease (ASCVD). The research was supported by the National Key Research And Development Program of China and published in Frontiers in Nutrition. [Extracted from the article]

A recent study conducted at Lorestan University of Medical Sciences explored the protective effect of betaine on rifampin-induced liver damage in rats. Rifampin, commonly used to treat tuberculosis, is known to be toxic to the liver. The study found that betaine administration reduced liver damage caused by rifampin, as evidenced by changes in serum biochemical factors and oxidative stress markers. This research sheds light on potential interventions to mitigate the harmful effects of antituberculosis agents on the liver. [Extracted from the article]

A patent application has been submitted for a composition and methods of treatment using synergistically-enhanced supplementation by inventor Alexy Goldstein. The application focuses on transdermal supplementation for improving metabolic performance through the use of medium-chain triglycerides, amino acids, hormone supplements, beta-hydroxybutyrate, and zeatin. The inventor emphasizes the need for tailored products to address different skin types and the underlying causes of skin damage. The patent application aims to provide a comprehensive approach to prevent and repair skin damage by addressing oxidative stress and glycation processes. [Extracted from the article]

A patent application titled "Composition And Methods Of Treatment Using Synergistically - Enhanced Supplementation" by inventor Alexy Goldstein discusses a supplement formulation for improving metabolic performance through transdermal and oral administration. The formulation includes medium-chain triglycerides, amino acids like carnitine, and forms of beta-hydroxybutyrate. The application emphasizes the need for tailored skincare products to address different skin types and prevent long-term damage. The patent application was filed on June 20, 2023, and made available online on December 5, 2024. [Extracted from the article]

A patent application has been submitted for a composition and methods of treatment using synergistically-enhanced supplementation by inventor Alexy Goldstein. The application focuses on providing a supplement formulation for humans that includes various compounds to improve metabolic performance and skin health. The inventor's goal is to address the underlying causes of skin damage and provide tailored products for different skin types. The patent application outlines methods for transdermal, oral, and transdermal supplementation using specific ingredients like medium-chain triglycerides, amino acids, hormones, and penetration enhancers. [Extracted from the article]

A patent application has been submitted for a composition and methods of treatment using synergistically-enhanced supplementation by inventor Alexy Goldstein. The application focuses on providing a supplement formulation for humans with therapeutically-beneficial additional compounds to improve metabolic performance. The formulation includes amino acids and beta-hydroxybutyrate in various forms, such as L-carnitine fumarate, and can be administered orally or transdermally. The goal is to address skin damage by stopping oxidative stress and glycation processes, tailoring products to different skin types for optimal protection and restoration. [Extracted from the article]

A recent study conducted in Maharashtra, India, focused on a couple experiencing infertility due to male factor asthenozoospermia and increased sperm DNA fragmentation. The male partner received acetyl-L-carnitine and L-carnitine supplementation, leading to improved sperm motility and reduced DNA fragmentation. The female partner underwent estrogen and platelet-rich plasma treatment to increase endometrial thickness and receptivity. The combined management of supplements, IMSI, and PRP proved successful in achieving a pregnancy through IVF, highlighting the importance of addressing both male and female infertility factors. [Extracted from the article]

A recent study from the University of Texas Southwestern Medical Center examined the relationship between dietary choline intake and the risk of colorectal cancer (CRC), with a focus on how B vitamin supplementation may modify this risk. The study found that higher dietary choline intake may be associated with an increased risk of CRC and its precursors, such as polyps. However, the potential modifying role of B vitamins was inconclusive, highlighting the need for larger-scale research to further explore these associations and assess the potential of dietary interventions in reducing CRC risk. The study was funded by the Arkansas Center For Health Disparities and published in the journal Nutrients. [Extracted from the article]

The article discusses the relationship between trimethylamine N-oxide (TMAO) levels and atherosclerosis risk in rodents. It explores the impact of different choline intake methods, such as oral gavage and dietary supplementation, as well as fasting conditions on TMAO production. The study suggests that acute oral choline gavage is suitable for studying acute inhibitors, while a choline-rich diet is more appropriate for assessing alterations in TMAO production capacity. Further research is recommended to understand the implications of TMAO regulation on cardiovascular health. [Extracted from the article]

A study conducted at Islamic Azad University examined the effects of L-carnitine supplementation on inflammatory responses and blood pressure changes following resistance exercise in non-athletic overweight young men. The research found that L-carnitine supplementation led to increased levels of L-carnitine and IL-4, and decreased levels of IL-8 and TNFa compared to the control group. The study suggested that L-carnitine supplementation may help prevent inflammation caused by acute resistance exercise. For more information, readers can refer to the International Journal of Nutrition Sciences. [Extracted from the article]

A recent study conducted at Osaka University in Japan introduced a novel choline-deficient and 0.1%-methionine-added high-fat diet that induces metabolic-dysfunction-associated steatohepatitis (MASH) in mice without severe body weight loss. The research aimed to create a more accurate animal model for human MASH to evaluate potential drug efficacy. The study found that the MASH diet accelerated lipid accumulation and liver fibrosis, with immune cell infiltration potentially contributing to the initiation of MASH pathogenesis. This model could serve as a valuable pre-clinical tool for developing treatments for human MASH. [Extracted from the article]

Research from the Korea National Institute of Health in Cheongju, South Korea, explores the role of palmitoyl-L-carnitine in Alzheimer's disease (AD) pathology. The study suggests that elevated levels of this metabolite in aged mice may contribute to AD through mechanisms such as tau phosphorylation and mitochondrial dysfunction. The findings highlight the significance of lipid metabolism in neurodegeneration and offer potential therapeutic targets for age-related diseases like AD. [Extracted from the article]

Researchers have submitted a patent application for "Brandy Replicas" that aims to replicate the taste, aroma, and characteristics of traditional brandies using specific compounds. The methods described in the patent application reduce risks and variability associated with traditional brandy production, offering reproducibility and flexibility in flavor optimization. The brandy replicas include various ingredients such as water, grain neutral spirits, oak extract, tannins, fruit juice, and added volatile compounds, with the possibility of including non-volatile compounds for color and flavor enhancement. [Extracted from the article]

The research conducted at Roswell Park Comprehensive Cancer Center in Buffalo, New York, focuses on the role of platelet-activating factor (PAF) in the tumor microenvironment (TME) and its impact on cancer immunotherapy. The study suggests that inhibiting PAF signaling could enhance cytotoxic T-cell activity by reducing myeloid-derived suppressor cell (MDSC)-mediated immunosuppression. This approach shows promise in improving cancer immunotherapy outcomes, especially when combined with checkpoint blockade therapies. For more information, readers can refer to the article "Platelet-activating Factor: a Potential Therapeutic Target To Improve Cancer Immunotherapy" published in Molecular Oncology. [Extracted from the article]

A recent study conducted in China investigated the impact of long-term dietary choline intake on cognitive decline in middle-aged and older adults. The study found that higher choline and phosphatidylcholine (PC) intakes were associated with a lower risk of cognitive decline, particularly in females and individuals over 65 years old. The research highlights age and gender disparities in the protective effects of dietary choline on cognitive health in the Chinese population. [Extracted from the article]

A recent study from Bogomolets National Medical University in Kyiv, Ukraine, examined the effects of L-carnitine supplementation on lipid profiles in adult patients undergoing hemodialysis. The study, which included 28 randomized clinical trials with 1,340 hemodialysis patients, found that L-carnitine supplementation did not significantly impact serum lipid levels, body mass index, or blood pressure. The research suggests that L-carnitine supplementation may not lead to significant improvements in these parameters for hemodialysis patients. [Extracted from the article]

A clinical trial conducted at Ain Shams University in Cairo, Egypt, explored the impact of L-carnitine supplementation on gastric emptying and bowel function in children following a ketogenic diet for drug-resistant epilepsy. The study found that L-carnitine supplementation improved gastric motility and increased the frequency of defecation in pediatric patients. Further research is recommended to explore additional benefits of L-carnitine supplementation in this context. The study was supported by Ain Shams University and published in Scientific Reports. [Extracted from the article]

Researchers at the University of Maribor in Slovenia have synthesized and purified a choline betainate compound with potential applications in muscle relaxant drugs. The compound showed high cytotoxicity for mouse fibroblasts and low antibacterial activity against certain strains. Funded by the European Union and the Slovenian Research and Innovation Agency, this peer-reviewed study provides insights into the synthesis, purification, and cell-toxicity of choline betainate. For more information, readers can refer to the Journal of Molecular Structure. [Extracted from the article]

A recent study conducted at Harokopio University in Athens, Greece, explored the effects of resveratrol, tyrosol, and their derivatives on platelet-activating factor biosynthesis in U937 cells. The research found that resveratrol and its methoxy derivative reduced PAF biosynthetic enzymes' activity, while tyrosol did not have a substantial effect. Additionally, lower concentrations of resveratrol and higher concentrations of the methoxy derivative increased lyso-PAF acetyltransferase activity via p38 mitogen-activated protein kinase action. The study sheds light on the potential protective effects of wine and olive oil phenolic compounds in atherosclerotic diseases. [Extracted from the article]

Researchers from Ain Shams University conducted a study on the potential protective effects of L-carnitine against testicular oxidative stress induced by chlorambucil therapy in adult male albino rats. The study involved four groups of rats receiving different treatments for 21 days, with histological analysis revealing significant damage in the chlorambucil-treated group, which was ameliorated in the group co-administered with L-carnitine. The research concluded that antioxidants like L-carnitine may offer protection against tissue injuries caused by chlorambucil therapy. The study was published in QJM: An International Journal of Medicine and can be accessed for further information. [Extracted from the article]

A recent study conducted at the Transplant Research Center focused on the effects of l-carnitine supplementation on frailty status and liver function in patients with liver cirrhosis. The study, which involved 77 participants, found that l-carnitine administration led to a significant decrease in alanine transaminase levels and improvements in coagulation status. However, the study did not show significant improvements in frailty measures after an 8-week intervention period. The research suggests that l-carnitine may have hepatoprotective properties but may not significantly impact frailty in liver cirrhosis patients. [Extracted from the article]

A study conducted at the University of Western Ontario explored the role of a primate-specific 82-kDa choline acetyltransferase in attenuating Alzheimer's disease-like pathology in a mouse model. The research found that mice expressing this enzyme showed reduced cognitive decline, amyloidosis, and gliosis, suggesting a potential role in decreasing AD-like pathology. The study highlights the importance of understanding the mechanisms underlying Alzheimer's disease progression. [Extracted from the article]

A study conducted at the University of Southern California (USC) focused on a case of a 24-year-old male who experienced a life-threatening episode of rhabdomyolysis, renal failure, altered mental status, and hyperammonemia after strenuous exercise. The research highlighted the importance of diagnosing 3-methylcrotonyl-CoA carboxylase (3-MCC) deficiency, a condition that can be detected through newborn screening and may have serious implications if left untreated. The study emphasized the need for periodic evaluation of plasma carnitine levels in asymptomatic adults with 3-MCC deficiency to prevent potential life-threatening episodes. [Extracted from the article]

A recent study from the University of Chile highlights the importance of prenatal choline intake in fetal development and its potential impact on neurodevelopmental disorders. Maternal choline intake has been shown to influence gene expression, epigenetics, and brain development in preclinical models. The research emphasizes the need for further investigation into the timing, dosage, and molecular mechanisms of choline supplementation to potentially mitigate cognitive and developmental disorders such as Rett syndrome, fragile X syndrome, and Down syndrome. The ultimate goal of the study is to underscore the significance of choline for maternal health and its potential benefits for neurodevelopmental disorders. [Extracted from the article]

A study conducted at Chongqing Medical University in the People's Republic of China focused on the development of a new nanomedicine called the "nano-windmill," which demonstrated superior anti-inflammatory effects by reducing choline uptake to inhibit macrophage activation. The research, funded by various foundations, highlighted the potential of this nanomedicine in treating chronic and acute inflammatory diseases. The study's findings were published in Cell Proliferation and can be accessed online for further information. [Extracted from the article]

A study from Tabriz University of Medical Sciences in Iran explored the potential of L-carnitine (LC) as a replacement for tumor necrosis factor-alpha (TNF-a) blockers. The research, which included a systematic review and meta-analysis of randomized controlled trials, found that oral LC supplementation did not significantly impact TNF-a levels, while parenteral LC did reduce TNF-a levels. The study concluded that oral LC supplementation was not superior to TNF-a blockers. More information on this research can be found in the Pharmaceutical Sciences journal. [Extracted from the article]

A study conducted by Army Medical University in Chongqing, China, explored the effects of L-carnitine on exertional heatstroke-induced myocardial injury in rats. The research found that L-carnitine had a protective effect on cardiac dysfunction and mortality in rats with exertional heatstroke, reducing negative effects such as myocardial apoptosis and enzyme activity levels. The study suggested that L-carnitine may reduce myocardial injury by inhibiting the PERK pathway associated with endoplasmic reticulum stress in exertional heatstroke. The findings indicate that L-carnitine supplementation could be a potential strategy to mitigate myocardial damage in exertional heatstroke cases. [Extracted from the article]

A study conducted at the University of Insubria in Varese, Italy, focused on the role of betaine in modulating GABA homeostasis through the GAT1 transporter in the central nervous system. The research suggests that betaine can act as a neuromodulator, improving GABA homeostasis and providing neuroprotection against excitotoxicity. The study, supported by HORIZON EUROPE Marie Sklodowska-Curie Actions, utilized various techniques such as electrophysiology and molecular dynamics simulation to explore the mechanisms behind betaine's neuroprotective effects. This research has been peer-reviewed and published in Cellular and Molecular Life Sciences. [Extracted from the article]

A study conducted at Lanzhou University in the People's Republic of China examined the effects of acesulfame potassium (Ace-K) on metabolic health in male C57BL/6 mice. The research found that Ace-K disrupted gut microbiota, leading to inflammation and altered fatty acids metabolism, ultimately causing the accumulation of fatty acids in the liver. These findings shed light on the mechanisms through which Ace-K induces hepatic inflammation and fatty acids accumulation. [Extracted from the article]

A recent study conducted by researchers at Ajou University School of Medicine in South Korea explores the role of Platelet-Activating Factor (PAF) in the pathogenesis of Chronic Spontaneous Urticaria (CSU). PAF, produced by various immune cells, induces mast cell degranulation and inflammatory responses, contributing to the development of CSU. The study highlights the potential of anti-PAF agents like Rupatadine and heat shock protein 10 in managing CSU, emphasizing the need for further therapeutic options targeting PAF. For more information, readers can refer to the International Journal of Molecular Sciences. [Extracted from the article]

A recent study from Tianjin University in China explores the use of zwitterionic betaine-based solutions for cryopreserving skin, aiming to prevent ice crystal formation and damage. The research identifies interfacial ice nucleation, stress accumulation, and thermal stress escalation as key factors in skin cryoinjury. The study's findings suggest that the novel cryoprotective agent formulation successfully preserves skin integrity and Young's modulus during cryopreservation, offering valuable insights for regenerative medicine and organ transplantation. For more information, the full article can be accessed through the American Association for the Advancement of Science (AAAS) website. [Extracted from the article]

Researchers at Zhejiang University in China conducted a study on the effects of coated cysteamine and choline chloride on fatty liver hemorrhagic syndrome in laying hens. The study found that dietary supplementation of these additives significantly reduced liver damage and improved antioxidant potential in hens with the syndrome. The researchers concluded that adding cysteamine and choline chloride could be an effective way to mitigate the harmful effects of fatty liver hemorrhagic syndrome in laying hens. [Extracted from the article]

A new study conducted by researchers at Ain Shams University explores the impact of L-carnitine supplementation on gastric emptying and bowel function in pediatric ketogenic diet therapy. The study involved 30 patients with drug-resistant epilepsy who were assigned to either receive the ketogenic diet with L-carnitine supplementation or the diet alone. Results showed that L-carnitine supplementation improved gastric motility and increased the frequency of defecation in patients. Further research is recommended to explore additional benefits of L-carnitine supplementation in such cases. [Extracted from the article]

Researchers from Taipei Medical University conducted a study on the role of the cerebellum in Parkinson's disease and essential tremor, using MRI and MRS to analyze anatomical and metabolic differences. The study found similarities in cerebellar structures and metabolic profiles between essential tremor and Parkinson's disease with tremor, suggesting the need for advanced imaging techniques to differentiate between the two conditions. The research highlights the potential therapeutic target of the cerebellum in treating neurocircuitry of Parkinson's disease and essential tremor. [Extracted from the article]

The article discusses the anaerobic metabolism of dietary choline by the human gut microbiome, which can lead to disease. Elevated serum levels of trimethylamine-N-oxide (TMAO) have been linked to cardiometabolic disease. The study highlights the potential therapeutic benefits of inhibiting gut bacterial choline metabolism to prevent disease development. The research uses phenotypic high-throughput screening to identify chemical compounds that can modulate microbial choline metabolism and reduce TMAO levels in vivo. [Extracted from the article]

A study conducted at Hokkaido University in Sapporo, Japan, explored the use of L-carnitine as a preventive measure for postoperative atrial fibrillation in patients undergoing lung cancer surgery. The research found that the incidence of atrial fibrillation was 38.5% in patients who received L-carnitine perioperatively. Serum FABP4 levels were identified as a potential biomarker for predicting postoperative atrial fibrillation. This study provides new insights into the use of L-carnitine as a therapeutic option for preventing atrial fibrillation in non-cardiac surgery patients. [Extracted from the article]

An international team of researchers, led by Baylor College of Medicine, identified a genetic diagnosis for 30 individuals with undiagnosed conditions using the FLVCR1 gene. The gene mutation affects red blood cell production and choline and ethanolamine transport in cells, leading to severe developmental disorders, epilepsy, and insensitivity to pain. The study highlights the importance of considering a wide range of symptoms and incorporating model organism data in diagnosing rare diseases. The findings suggest potential therapeutic value in choline or ethanolamine supplementation for FLVCR1-related diseases. [Extracted from the article]